NDA 208299 describes ROFLUMILAST, which is a drug marketed by
Alkem Labs Ltd,
Aurobindo Pharma Ltd,
Breckenridge,
Hetero Labs Ltd Iii,
Micro Labs,
MSN,
Mylan,
Prinston Inc,
Strides Pharma,
Torrent, and
Zydus Pharms, and is included in eleven NDAs. It is available from
eleven suppliers. Additional details are available on the
ROFLUMILAST profile page.
The generic ingredient in ROFLUMILAST is
roflumilast. There are ten
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
roflumilast profile page.